Proposed model links accumulated Aβ oligomer neurotoxicity to neuronal biological age
The abstract proposes accumulated neurotoxicity, the time integral of Aβ oligomer concentration, as a biomarker of neuronal aging and describes a numerical model linking biological and calendar age. It reports that longer Aβ half-lives with age accelerate biological aging and that biological age is modeled as irreversible and path dependent. [1]
Automatic summary · not editorially reviewed
The key findings
The study proposes accumulated neurotoxicity, the time integral of Aβ oligomer concentration, as a biomarker for neuronal aging. [1]
The findings indicate that increasing the half-life of Aβ monomers and oligomers with age accelerates biological aging. [1]
The model demonstrates that biological age is irreversible and path dependent rather than state dependent. [1]
The source at a glance
- Study type / format
- Numerical modeling study (abstract)
- Population / context
- Neurons in a numerical model of Aβ monomer and oligomer dynamics; no human participants described.
- Summary based on
- Study abstract
- Original publication
- September 1, 2026
Proposed Aβ oligomer neurotoxicity biomarker for neuronal aging
This study proposes using accumulated neurotoxicity, defined as the time integral of Aβ oligomer concentration, as a biomarker for neuronal aging. It proposes a relationship between biological age and this accumulated neurotoxicity. Numerical analysis guided the development of a new analytical solution linking the biological and calendar ages of neurons. The work is a modeling proposal, not a measured human outcome.
Supporting source [1]
Modeled effects of Aβ half-lives and monomer production
The model examines how the half-lives of Aβ monomers and oligomers, described as key indicators of proteolytic efficiency, affect biological age, under both constant and age-dependent (exponentially increasing) half-life scenarios. The findings indicate that increasing the half-life of Aβ monomers and oligomers with age accelerates biological aging. Reducing Aβ monomer production is shown to slow biological aging, with a linear relationship established between these two quantities. Biological age is also found to depend linearly on the half-deposition time of Aβ oligomers into senile plaques.
Supporting source [1]
Modeled irreversibility and path dependence of biological age
The model demonstrates that biological age is irreversible, which the authors present as a theoretical explanation for why plaque-clearing therapies cannot reverse established cognitive impairment. It also demonstrates that biological age is path dependent rather than state dependent. These are model results and theoretical interpretations, not clinical evidence that such therapies fail in patients.
Supporting source [1]
How to interpret this
Abstract only; the full text was not reviewed. This is a numerical modeling study proposing a biomarker and analytical solution, not a clinical or human study. The reported relationships, including irreversibility and the explanation for plaque-clearing therapies, are model results and theoretical interpretations, not measured outcomes in patients.
Based on the study abstract; the full paper, tables and supplementary data were not reviewed.
Source & supporting passages
Kuznetsov AV. · europepmc.org · September 1, 2026